Zzapp Malaria

Company Overview

Snapshot

Founded in November 2016, Zzapp Malaria operates with 1–10 employees. The company has secured $3.49 million in total capital across four funding rounds. A significant milestone for the company was winning the IBM Watson XPRIZE AI for Good competition, which included a $3 million grand prize, highlighting its innovative approach to malaria eradication.

Business overview

Zzapp Malaria is dedicated to eradicating malaria through an AI-based platform designed to enhance the effectiveness and reduce the costs of large-scale anti-malaria operations. Its core technology integrates a command center that automates operational planning using satellite imagery, topography, and weather data, with a mobile app for execution tracking and ground-level data collection. The company serves public health initiatives and government entities in regions affected by malaria, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support.

Strategic signal

In June 2023, Zzapp Malaria was featured for its app-based strategy to prevent malaria-carrying mosquitoes from reproducing. This highlights the company's continued focus on leveraging technology for proactive disease control, signaling to investors a commitment to scalable and preventative health solutions in the global fight against malaria.

Company Intelligence Q&A

What is Zzapp Malaria's primary mission and technological approach?

Zzapp Malaria aims to eradicate malaria by developing an AI-based platform that significantly increases the effectiveness and reduces the costs of large-scale anti-malaria operations. The platform integrates a command center for automated planning using diverse data sources and a mobile app for field execution and data collection.

What significant recognition has Zzapp Malaria received for its technology?

Zzapp Malaria was the grand-prize winner of the IBM Watson XPRIZE AI for Good competition, receiving $3 million. The company also won the Cisco Global Problem Solver Challenge in 2021, recognizing its innovative approach to combating malaria.

What evidence supports the effectiveness of Zzapp Malaria's platform?

In two large controlled trials conducted in Ghana and São Tomé, Zzapp Malaria's platform demonstrated significant improvements in cost-effectiveness. It successfully reduced mosquito populations and malaria cases in both urban and rural settings, achieving costs competitive with existing methods.

With which major organizations does Zzapp Malaria collaborate?

Zzapp Malaria collaborates with the Gates Foundation and various institutes across six African countries, indicating strategic partnerships aimed at advancing its malaria eradication efforts.

What was a key focus of Zzapp Malaria's media coverage in June 2023?

In June 2023, Bloomberg highlighted Zzapp Malaria's app-based approach to targeting malaria-carrying mosquitoes at their source, focusing on preventing reproduction. This coverage emphasized the company's innovative strategy in vector control.